| Name | Title | Contact Details |
|---|
medical supply net is a San Dimas, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Scanlan Worldwide is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
SportsArt is the fitness industry leader in eco-innovation, unique design and green manufacturing excellence; and the only fitness company able to harness human energy and convert it into utility-grade electricity. We`ve built our reputation through rebuilding and sustaining lives in the fitness, medical rehabilitation, performance and wellness markets.
Integer Holdings Corporation (NYSE:ITGR) is a leader in advanced medical device outsourcing (MDO) and serves its customers by providing comprehensive end-to-end solutions with its unparalleled expertise in innovation and manufacturing. Integer`s vision is to enhance the lives of patients worldwide by being its customer`s partner of choice for innovative medical technologies and services. Additionally, through Electrochem, an Integer company, it develops custom batteries for high-end niche applications in energy, military, and environment markets. The company`s medical device manufacturing brands include Greatbatch™ Medical and Lake Region Medical™.
Motif Neurotech is a clinical-stage company leading the development of minimally invasive neuromodulation therapeutics for mental health. The company`s lead product, for treatment resistant depression (TRD), is a miniature implant that is designed to treat TRD by increasing activity in the prefrontal cortex. Studies over 20 years show stimulation of the pre-frontal cortex effectively treats treatment resistant depression without the side effects of anti-depressants. However, existing brain stimulation treatments like transcranial magnetic stimulation (TMS) can be expensive and challenging for patients to access, with daily treatments required for six weeks that may need to be repeated. Human and large animal studies show Motif`s prototype stimulates target brain areas like TMS, and the company is preparing to begin clinical trials of their first chronic implants in 2025. Motif`s implant is enabled by patent-pending wireless magnetoelectric power transfer developed at Rice University. Motif`s founders and key team members are clinical, medical device and academic experts with over 5,000 surgical procedures and decades of medical device experience.